Incyte's (INCY) "Opzelura Miss is Likely to Weigh on Shares" - BMO Capital Keeps Stock at Market Perform with $81 Price Target Post Q2 Earnings
Tweet Send to a Friend
BMO Capital analyst Evan David Seigerman reiterated a Market Perform rating and $81.00 price target on Incyte (NASDAQ: INCY), following ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
